No Data
Soracom Announces Connected Car Strategy
Ishin, JSH, Hatchwork, Solacom, Dai, Sinka, Cauris, information global strategy technology
■ ISIN <143A> Estimated number of shares to be released: 1,344,700 shares (estimated) Release date: 09/21/2024 Target shareholders: Estimated Shares: Tomoyoshi Akashi - 432,200 shares Michio Matsuura - 19,200 shares (Shares) Bright Stone - 760,000 shares Kazutaka Muraguchi - 53,300 shares Satoshi Kitaoka - 32,000 shares Hideaki Yoshida - 16,000 shares Hirohiro Maruyama - 16,000 shares Dai Matsumoto
Soracom: (Correction) Regarding a partial correction to the 'Fiscal Year March 2025 First Quarter Financial Results Presentation Materials'.
Volume change rate ranking (9:00) - Ice Style, Pepper and others ranked.
In the volume change rate ranking, you can know the interest of market participants such as the trend of scouting by comparing the volume of the recent 5-day average with the volume on the delivery day. Top volume change rate [As of 9:32 am, August 15th] (Comparison of recent 5-day average volume): Code Name Volume 5-day average volume Volume change rate Stock price change rate <3053> Pepper 1566400 107185.08 224.08% 0.32.
The market is weak and dominated by selling on rebounds, but the downside is showing resilience.
[Emerging markets individual stock strategy] A sluggish trend is expected in today's emerging markets. On the 14th, in the US stock market, the Dow Jones average continued to rise to 40,008.39, up 242.75 dollars (+0.61%). Buying was expected to decrease due to confirmed inflation slowdown in the July Consumer Price Index (CPI), causing expectations of a rate cut. Additionally, the retreat of pessimistic views on the economy supported stock prices. Today's emerging markets are likely to be dominated by selling. The Tokyo Stock Exchange Growth Market Index was at 6 until yesterday.
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
No Data
No Data